Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Pavord, Ian D, Prof, Korn, Stephanie, MD, Howarth, Peter, DM, Bleecker, Eugene R, Prof, Buhl, Roland, Prof, Keene, Oliver N, MSc, Ortega, Hector, MD, Chanez, Pascal, MD
Published in The Lancet (British edition) (18.08.2012)
Published in The Lancet (British edition) (18.08.2012)
Get full text
Journal Article
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Ortega, Hector G, Yancey, Steven W, Mayer, Bhabita, Gunsoy, Necdet B, Keene, Oliver N, Bleecker, Eugene R, Brightling, Christopher E, Pavord, Ian D
Published in The lancet respiratory medicine (01.07.2016)
Published in The lancet respiratory medicine (01.07.2016)
Get more information
Journal Article
Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Yancey, Steven W., MSc, Ortega, Hector G., MD, Keene, Oliver N., MSc, Mayer, Bhabita, MSc, Gunsoy, Necdet B., PhD, Brightling, Christopher E., PhD, Bleecker, Eugene R., MD, Haldar, Pranabashis, MRCP, Pavord, Ian D., FMedSci
Published in Journal of allergy and clinical immunology (01.04.2017)
Published in Journal of allergy and clinical immunology (01.04.2017)
Get full text
Journal Article